UY30460A1 - Compuestos terapéuticos - Google Patents

Compuestos terapéuticos

Info

Publication number
UY30460A1
UY30460A1 UY30460A UY30460A UY30460A1 UY 30460 A1 UY30460 A1 UY 30460A1 UY 30460 A UY30460 A UY 30460A UY 30460 A UY30460 A UY 30460A UY 30460 A1 UY30460 A1 UY 30460A1
Authority
UY
Uruguay
Prior art keywords
therapeutic compounds
methods
solvates
preparing
formula
Prior art date
Application number
UY30460A
Other languages
English (en)
Inventor
Rongliang Chien
Scott Channing Sutton
Simon Paul Planken
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY30460A1 publication Critical patent/UY30460A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

La presente invencion proporciona compuestos de formula (I), o sales o solvatos de los mismos farmacéuticamente aceptables, procedimientos para prepararlos, procedimientos para usarlos y formulaciones farmacéuticas que los comprenden.
UY30460A 2006-07-05 2007-07-04 Compuestos terapéuticos UY30460A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80659606P 2006-07-05 2006-07-05
US91098807P 2007-04-10 2007-04-10
US94180807P 2007-06-04 2007-06-04

Publications (1)

Publication Number Publication Date
UY30460A1 true UY30460A1 (es) 2008-02-29

Family

ID=38515807

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30460A UY30460A1 (es) 2006-07-05 2007-07-04 Compuestos terapéuticos

Country Status (24)

Country Link
US (1) US7919488B2 (es)
EP (1) EP2046774A1 (es)
KR (1) KR20090034958A (es)
CN (1) CN101511812A (es)
AP (1) AP2009004763A0 (es)
AR (1) AR062154A1 (es)
AU (1) AU2007270814B2 (es)
CA (1) CA2660031A1 (es)
CO (1) CO6150178A2 (es)
CR (1) CR10573A (es)
EA (1) EA200900135A1 (es)
GT (1) GT200700053A (es)
IL (1) IL196490A0 (es)
MA (1) MA30629B1 (es)
MX (1) MX2009000482A (es)
NO (1) NO20090346L (es)
NZ (1) NZ574207A (es)
PE (1) PE20080998A1 (es)
RS (1) RS20090036A (es)
TN (1) TN2009000033A1 (es)
TW (1) TWI334867B (es)
UY (1) UY30460A1 (es)
WO (1) WO2008004096A1 (es)
ZA (1) ZA200900478B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2669917A1 (en) * 2006-11-17 2008-05-22 Dawn M. George Aminopyrrolidines as chemokine receptor antagonists
AU2007349176A1 (en) * 2007-03-13 2008-09-18 Arete Therapeutics, Inc. 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
WO2009102893A2 (en) 2008-02-14 2009-08-20 Amira Pharmaceuticals, Inc. CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
US8426449B2 (en) 2008-04-02 2013-04-23 Panmira Pharmaceuticals, Llc Aminoalkylphenyl antagonists of prostaglandin D2 receptors
DE102009041241A1 (de) 2009-09-11 2011-08-04 Bayer Schering Pharma Aktiengesellschaft, 13353 Substituierte Aryl-Verbindungen und ihre Verwendung
DE102008057344A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Aminoalkyl-substituierte Aryl-Verbindungen und ihre Verwendung
DE102009041242A1 (de) 2009-09-11 2011-12-15 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch substituierte Aryl-Verbindungen und ihre Verwendung
DE102008057364A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Substituierte Aryl-Verbindungen und ihre Verwendung
DE102008057343A1 (de) 2008-11-14 2010-05-20 Bayer Schering Pharma Aktiengesellschaft Heterocyclisch substituierte Aryl-Verbindungen und ihre Verwendung
US8383654B2 (en) 2008-11-17 2013-02-26 Panmira Pharmaceuticals, Llc Heterocyclic antagonists of prostaglandin D2 receptors
CN107021951B (zh) 2010-06-30 2020-10-20 赛克里翁治疗有限公司 sGC刺激物
AU2011326241B2 (en) 2010-11-09 2016-11-17 Ironwood Pharmaceuticals, Inc. sGC stimulators
CN106117194A (zh) 2011-12-27 2016-11-16 铁木医药有限公司 可用作sgc刺激剂的2‑苄基、3‑(嘧啶‑2‑基)取代的吡唑类
CN104540813A (zh) * 2012-06-27 2015-04-22 默沙东公司 磺酰胺衍生物以及使用它们用于改善药物的药物动力学的方法
WO2014000178A1 (en) * 2012-06-27 2014-01-03 Merck Sharp & Dohme Corp. Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug
WO2015070366A1 (en) 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
WO2015070367A1 (en) * 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
US20220144797A1 (en) * 2019-02-08 2022-05-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education 20-hete formation inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024795D0 (en) 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases
JP4485744B2 (ja) * 2001-04-05 2010-06-23 トレント・ファーマシューティカルズ・リミテッド 老化−関連及び糖尿病性血管性合併症のための複素環式化合物
US7008953B2 (en) * 2003-07-30 2006-03-07 Agouron Pharmaceuticals, Inc. 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
US7662844B2 (en) * 2004-07-12 2010-02-16 Osi Pharmaceuticals, Inc. Naphthylene derivatives as cytochrome P450 inhibitors
WO2007034312A2 (en) * 2005-09-23 2007-03-29 Pfizer Products Inc. Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)

Also Published As

Publication number Publication date
RS20090036A (en) 2010-06-30
TWI334867B (en) 2010-12-21
CN101511812A (zh) 2009-08-19
AU2007270814B2 (en) 2011-07-14
PE20080998A1 (es) 2008-08-15
MX2009000482A (es) 2009-01-27
US7919488B2 (en) 2011-04-05
KR20090034958A (ko) 2009-04-08
NZ574207A (en) 2010-10-29
AP2009004763A0 (en) 2009-02-28
GT200700053A (es) 2009-08-03
ZA200900478B (en) 2010-04-28
US20080021011A1 (en) 2008-01-24
CR10573A (es) 2009-02-12
EA200900135A1 (ru) 2009-06-30
WO2008004096A1 (en) 2008-01-10
CA2660031A1 (en) 2008-01-10
EP2046774A1 (en) 2009-04-15
NO20090346L (no) 2009-02-19
CO6150178A2 (es) 2010-04-20
AU2007270814A1 (en) 2008-01-10
IL196490A0 (en) 2011-07-31
TW200811159A (en) 2008-03-01
AR062154A1 (es) 2008-10-22
MA30629B1 (fr) 2009-08-03
TN2009000033A1 (fr) 2010-08-19

Similar Documents

Publication Publication Date Title
UY30460A1 (es) Compuestos terapéuticos
ECSP088296A (es) Compuestos terapéuticos
CR11106A (es) Inhibidores de cinasa p710 s6
LTPA2016016I1 (lt) Azetinidai kaip mek inhibitoriai, skirti proliferacinių ligų gydymui
UY31027A1 (es) Derivados de tetrahidroindol y tetrahidroindazol
CR11857A (es) Compuestos pirazolicos 436
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
UY30977A1 (es) Derivados de isoindolinas 4' -o-sustituidas. composiciones que las contienen y metodos para sus usos.
DOP2010000134A (es) Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos
CU23779B7 (es) Compuestos de pirazolina y su uso y composiciones farmacéuticas
DOP2006000193A (es) Compuestos de isoindol-imida y composiciones que los incluye y metodos para su uso
DOP2011000203A (es) Derivados de pirimidin indol para el tratamiento de cancer
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
ECSP109934A (es) Compuesto - 946
CR11333A (es) cis-IMIDAZOLINAS QUIRALES
UY27226A1 (es) Pirazolopirimidinas como agentes terapéuticos
UY32203A (es) Amino pirimidinas y su uso en terapia
CO6270311A2 (es) Derivados bis-(sulfonilamino) en terapia 066
UY28671A1 (es) Pirido(2.3-d)pirimidina-2,4-diaminas como inhibidores de pde 2
DOP2006000243A (es) Derivados de pirazina
UY33075A (es) Derivados de ciclohexano y usos de los mismos
CR10314A (es) Compuestos que tienen actividad en el receptor m 1 y sus usos en medicina
UY30377A1 (es) Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
UY30029A1 (es) Derivados de piperidina, sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120606